98%
921
2 minutes
20
We present a new test-the UNSW Face Test (www.unswfacetest.com)-that has been specifically designed to screen for super-recognizers in large online cohorts and is available free for scientific use. Super-recognizers are people that demonstrate sustained performance in the very top percentiles in tests of face identification ability. Because they represent a small proportion of the population, screening large online cohorts is an important step in their initial recruitment, before confirmatory testing via standardized measures and more detailed cognitive testing. We provide normative data on the UNSW Face Test from 3 cohorts tested via the internet (combined n = 23,902) and 2 cohorts tested in our lab (combined n = 182). The UNSW Face Test: (i) captures both identification memory and perceptual matching, as confirmed by correlations with existing tests of these abilities; (ii) captures face-specific perceptual and memorial abilities, as confirmed by non-significant correlations with non-face object processing tasks; (iii) enables researchers to apply stricter selection criteria than other available tests, which boosts the average accuracy of the individuals selected in subsequent testing. Together, these properties make the test uniquely suited to screening for super-recognizers in large online cohorts.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668578 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241747 | PLOS |
BMC Public Health
September 2025
Heidelberg Institute of Global Health, Heidelberg University, Bergheimer Str. 20, Zimmer 317, 69115, Heidelberg, Germany.
Background: People living in prison face exceptionally high prevalence rates of tooth decay, periodontal disease, and poor oral health-related quality of life. Despite its importance, various aspects of oral healthcare in prison settings remain understudied. The present study investigates the barriers and facilitators associated with providing and utilizing oral health services in prison settings, drawing on insights from prison health experts, managerial and custodial staff, healthcare providers, and individuals with lived experience of imprisonment.
View Article and Find Full Text PDFDiabetes Care
August 2025
Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, WA.
In type 1 diabetes, a condition that necessitates lifelong exogenous insulin replacement, there is heavy reliance on technology-assisted insulin delivery and glucose monitoring. Yet, people living with type 1 diabetes still face dysglycemia, weight gain, vascular complications, ketoacidosis and severe hypoglycemia, and psychological distress. Cardiovascular and kidney disease remain the leading causes of morbidity and mortality, yet traditional risk factors (smoking, hypertension, hyperlipidemia, obesity, hyperglycemia) incompletely explain this excess burden.
View Article and Find Full Text PDFNeural Netw
August 2025
College of Computer Science, TKLNDST, Nankai University, Tianjin, China.
The Internet of Things (IoT) has permeated all facets of modern life, offering revolutionary applications from smart homes to industrial automation. However, the widespread adoption of IoT systems has amplified security vulnerabilities, necessitating robust intrusion detection systems (IDSs) to protect these devices. Traditional IDS solutions often face challenges in resource-constrained IoT environments due to high computational demands and limited adaptability to emerging threats.
View Article and Find Full Text PDFJ Palliat Med
August 2025
Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT), Faculty of Health, University of Technology Sydney (UTS), Sydney, Australia.
Clinical trials are underway of medicinal cannabis for cancer-related anorexia, using various formulations and modes of administration. To explore the benefits and burdens of vaporized medicinal cannabis flower bud for anorexia from the perspectives of trial participants with advanced cancer and their carers. People with advanced cancer enrolled as inpatients in a Phase I/IIb clinical trial, and their carers participated in face-to-face semi-structured interviews.
View Article and Find Full Text PDFActa Anaesthesiol Scand
October 2025
Critical Care Program, The George Institute for Global Health, University of New South Wales (UNSW) Sydney, Sydney, New South Wales, Australia.
Background: The international multi-center randomized controlled STEPCARE-trial will investigate optimal management of sedation, temperature, and mean arterial pressure (MAP) during intensive care in out-of-hospital cardiac arrest (OHCA) patients due to various etiologies. The primary outcome is mortality at 6 months. This protocol describes an extended follow-up sub-study of the STEPCARE-trial with the main objective to provide detailed long-term outcomes for survivors and caregivers.
View Article and Find Full Text PDF